JAMA Pediatrics study tracks GLP-1 use versus bariatric surgery in teens
The cross-sectional analysis follows quarterly prescribing and surgical trends among adolescents who met eligibility criteria for metabolic and bariatric surgery.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 4 20:00 ETSource: JAMA pediatrics
The wire
- 01A cross-sectional study published in JAMA Pediatrics assesses quarterly trends in GLP-1 receptor agonist prescribing and metabolic and bariatric surgery use among surgery-eligible adolescents.
- 02Pediatric and adolescent obesity clinicians are weighing incretin therapy against surgical referral, and utilization data informs how that balance is shifting in practice.
- 03The design is cross-sectional and descriptive, so it shows utilization patterns rather than comparative outcomes, durability or safety between the two approaches.
From the source
Read at pubmed.ncbi.nlm.nih.govMetabolic and Bariatric Surgery and GLP-1 Receptor Agonist Use Among Adolescents
JAMA pediatrics · 2026 Oct 5 · Rode JB, Inge TH, Wu AD et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42832242/
